MyFinsight
Home
About
Contact
wgsww: the income statement
Download
Download image
Comprehensive loss
-$7,445K
Unrealized gain related to
available for sale...
$190K
Legacy Sema4
$1,717K
Gene Dx
$1,503K
Legacy Sema4
$329K
Gene Dx
$113,194K
Net loss
-$7,635K
Product And Service
Other
$3,220K
Diagnostic Test
$113,523K
Income tax (expense)
benefit
$247K
Loss before income
taxes
-$7,388K
Total revenue
$116,743K
Total non-operating
expense, net
-$4,137K
Loss (income) from
operations
-$3,251K
Gross profit
$84,527K
Cost of services
$32,216K
Other (expense)
income, net
-$174K
Interest expense, net
-$562K
Change in fair value of
financial liabilities
-$3,401K
General and
administrative
$44,439K
Selling and marketing
$23,510K
Research and development
$19,829K
Back
Back
Income Statement
source: myfinsight.com
GeneDx Holdings Corp. (WGSWW)
GeneDx Holdings Corp. (WGSWW)